Trial site
The Central Hospital of Yongzhou
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer3 trials
- COPD2 trials
- Triple-negative breast cancer2 trials
- Follicular lymphoma1 trial
- High blood pressure1 trial
- Neuroendocrine tumours1 trial
- Neuromyelitis optica (NMOSD)1 trial
- Stroke1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Status
- Recruiting4 trials
- Active, not recruiting3 trials
- Completed3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Biotheus Inc.2 trials
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
- Shanghai Jiaolian Drug Research and Development Co., Ltd2 trials
- Xiangya Hospital of Central South University2 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Not yet recruiting
Recruiting
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.
Active, not recruiting
A Study of PM8002 in Combination With Chemotherapy in Patients With NEN
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD2 recruiting
- Metastatic breast cancer2 recruiting
- Neuromyelitis optica (NMOSD)1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer
Completed
Bleeding Intracerebral Hemorrhage With Early Invasive Intracranial Pressure Monitoring Trial
Completed
Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
Site data: ClinicalTrials.govUpdated 12 Nov 2026